Zealand Pharma Establishes U.S. Research Hub to Accelerate Drug Discovery

Zealand Pharma has announced the establishment of a new research hub in Cambridge, Massachusetts, to bolster its global drug discovery capabilities. The strategic move aims to expand the company's research and development (R&D) footprint within the United States and tap into the premier biotech innovation ecosystem of the Boston area. The new facility will leverage Zealand Pharma's 25-year expertise in peptide-based medicines and metabolic health. This expansion is expected to accelerate the creation of novel therapies and enhance the company's long-term growth pipeline. By positioning itself in this key hub, the company intends to combine its specialized knowledge with the world-class talent pool available in the U.S. market. The initiative underscores Zealand Pharma's commitment to advancing its portfolio of innovative peptide treatments.

Sources:globenewswire.comaktiencheck.dezealandpharma.commarketscreener.combizjournals.com